BridgeMD
New treatment option for Sessile Colonic Polyp
Official title Computer-Aided Water Exchange Colonoscopy With and Without Linked-Color Imaging for Detection of Clinically Significant Serrated Lesions
ClinicalTrials.gov ID: NCT07127471
What this study is testing
- What it's testing
- The goal of this clinical trial is to compare the detection rate of clinically significant serrated lesions (CSSL) in participants undergoing water exchange (WE) colonoscopy with artificial intelligence (AI)-based computer-aided detection (CADe) for screening, surveillance, diagnosis for symptoms, or referred owing to a positive fecal immunochemical test (FIT) or guaiac fecal occult blood test (gFOBT) result. There will be two arms in this study: WE with AI-assisted CADe (WEAID) control and WEAID plus linked-color imaging (LCI).
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 to 80. Healthy volunteers may be eligible.
You may be able to join if
- Male and female patients aged 40-80 years scheduled for average-risk screening colonoscopy, post-polypectomy surveillance, diagnosis for...
You likely can't join if
- familial adenomatous polyposis and hereditary non-polyposis CRC syndrome
- personal history of serrated polyposis syndrome
- personal history of CRC
- history of inflammatory bowel disease
- previous colonic resection
- overt gastrointestinal bleeding
See the full eligibility criteria
- Male and female patients aged 40-80 years scheduled for average-risk screening colonoscopy, post-polypectomy surveillance, diagnosis for gastrointestinal symptoms (including unexplained iron deficiency anemia and...
- familial adenomatous polyposis and hereditary non-polyposis CRC syndrome
- personal history of serrated polyposis syndrome
- personal history of CRC
- history of inflammatory bowel disease
- previous colonic resection
- overt gastrointestinal bleeding
- emergency colonoscopy or inpatients
- planned EMR or ESD of large polyps
- colon stricture or obstruction
- contraindications to colonoscopy (eg, acute diverticulitis or toxic megacolon)
- antithrombotic therapy precluding complete polyp resection
- American Society of Anesthesiology classification of physical status \>3
- pregnant women or women planning pregnancy
- refusal to provide a written informed consent
The study team makes the final eligibility decision.
Where it's taking place
- Montreal, Quebec, Canada
- Como, Italy
- Taoyuan, Taiwan
- Bangkok, Thailand
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 40 years to 80 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Montreal, Quebec, Canada; Como, Italy; Taoyuan, Taiwan; Bangkok, Thailand. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.